It was reported that three (3) large volume folfusors had no flow during patient use.The expected therapy time was 24 hours; however, the next day after starting therapy, the devices "had not gone through at all and appeared full".The devices contained piperacillin/tazobactam 13.5g and citrate buffer in 230 ml sodium chloride 0.9%.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
|
Additional information was added to d9, h3, h4, h6, and h11: h4: the lot was manufactured between october 12, 2023 ¿ october 16, 2023.H11: three (3) actual devices were received for evaluation.Visual inspection did not identify any abnormalities that could have contributed to the no flow condition.A functional flow rate test was performed on the samples, and the flow rates were found to be within the product specification range.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|